Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.035 USD | -3.50% | -10.61% | +54.62% |
31/05 | Health Care Stocks Climb On Drug News -- Health Care Roundup | DJ |
31/05 | Larimar Therapeutics Shares Rise 15% Nomlabofusp Selected for FDA Program | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.62% | 45Cr | |
+16.45% | 12TCr | |
+21.96% | 12TCr | |
+25.47% | 2.7TCr | |
-20.05% | 2.04TCr | |
-16.28% | 1.59TCr | |
-15.94% | 1.64TCr | |
-44.35% | 1.56TCr | |
+63.91% | 1.49TCr | |
+2.52% | 1.36TCr |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Citigroup Adjusts Price Target on Larimar Therapeutics to $10 From $4.50, Maintains Buy Rating